Literature DB >> 33444831

Effect of Dorsal Root Ganglion Retraction in Endoscopic Lumbar Decompressive Surgery for Foraminal Pathology: A Retrospective Cohort Study of Interlaminar Contralateral Endoscopic Lumbar Foraminotomy and Discectomy versus Transforaminal Endoscopic Lumbar Foraminotomy and Discectomy.

Hyeun Sung Kim1, Ji Yeon Kim2, Pang Hung Wu3, Il-Tae Jang1.   

Abstract

OBJECTIVE: Postoperative dysesthesia (POD) is a common complication in surgery involving foraminal diseases, including lumbar foraminal or extraforaminal herniated nucleus pulposus (HNP). Minimal dorsal root ganglion (DRG) retraction is key to preventing POD. We compared the clinical results, safety, and efficacy between the paraspinal transforaminal approach requiring DRG retraction and the interlaminar contralateral approach without DRG retraction for foraminal and extraforaminal diseases.
METHODS: A retrospective cohort study was performed of 50 patients who underwent uniportal transforaminal endoscopic lumbar foraminotomy and discectomy (TELD) and 50 patients who underwent anuniportal interlaminar contralateral endoscopic lumbar foraminotomy and discectomy (ICELF) because of lumbar foraminal HNP. The operated levels, combined degenerative diseases, postoperative complications, and POD were analyzed. The visual analog scale (VAS) pain scores, modified Oswestry Disability Index, and MacNab criteria for evaluating pain disability and response were analyzed.
RESULTS: In the ICELF group (total, n = 7, 14%), there were 5 (10%) and 2 (4%) patients with POD grade 1 and 2, respectively. In the TELD group (total, n = 13, 26%), there were 7 (14%), 5 (10%), and 1 (2%) patients with POD grade 1, 2, and 3, respectively. The overall occurrence rate of grade 2 and greater POD was higher in the TELD group (n = 6, 12%) than in the ICELF group (n = 2, 4%). In the ICELF group, 3 of 9 patients (33%) with combined canal structure deforming diseases had POD, of whom none had POD of grade 2 and greater. In the TELD group, 4 of 7 patients (57%) with combined canal structure deforming diseases had POD, of whom all had POD of grade 2 and greater. Two surgical groups showed favorable clinical outcomes with the visual analog scale, Oswestry Disability Index, and MacNab criteria.
CONCLUSIONS: Both TELD and ICELF were found to treat foraminal or extraforaminal HNP with good clinical outcomes. ICELF might have a lower POD rate in complicated cases such as adjacent segment disease, degenerative spondylolisthesis, and isthmic spondylolisthesis. This surgical procedure could be an alternative in complicated cases or in patients with an anatomically limited L5-S1 level. However, the procedure is technically challenging to perform.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dorsal root ganglion; Dysesthesia; Endoscopic spinal surgery; Lumbar

Year:  2021        PMID: 33444831     DOI: 10.1016/j.wneu.2020.12.176

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Difficulties, Challenges, and the Learning Curve of Avoiding Complications in Lumbar Endoscopic Spine Surgery.

Authors:  Kai-Uwe Lewandrowski; Albert E Telfeian; Stefan Hellinger; Max R F Ramos; Hyeun Sung Kim; Daniel W Hanson; Nimar Salari; Anthony Yeung
Journal:  Int J Spine Surg       Date:  2021-12

2.  Remodeling Pattern of Spinal Canal after Full Endoscopic Uniportal Lumbar Endoscopic Unilateral Laminotomy for Bilateral Decompression: One Year Repetitive MRI and Clinical Follow-Up Evaluation.

Authors:  Hyeun-Sung Kim; Pang-Hung Wu; Giovanni Grasso; Jin-Woo An; Myeonghun Kim; Inkyung Lee; Jong-Seon Park; Jun-Hyoung Lee; Sangsoo Kang; Jeongshik Lee; Yeonjin Yi; Jun-Hyung Lee; Jun-Hwan Park; Jae-Hyeon Lim; Il-Tae Jang
Journal:  Diagnostics (Basel)       Date:  2022-03-24

3.  The Novel Technique of Uniportal Endoscopic Interlaminar Contralateral Approach for Coexisting L5-S1 Lateral Recess, Foraminal, and Extraforaminal Stenosis and Its Clinical Outcomes.

Authors:  Ji Yeon Kim; Hyeun Sung Kim; Jun Bok Jeon; Jun Hyung Lee; Jun Hwan Park; Il-Tae Jang
Journal:  J Clin Med       Date:  2021-03-26       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.